During the past decade, Hôpital Henri Mondor conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 7 clinical trials were completed, i.e. on average, 58.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hôpital Henri Mondor" #1 sponsor was "Gilead Sciences" with 5 trials, followed by "Pfizer" with 3 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Federation Francophone de Cancerologie Digestive" with 2 trials sponsored and "Actelion" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Henri Mondor" #1 collaborator was "DePuy Synthes" with 1 trials as a collaborator, "GERCOR - Multidisciplinary Oncology Cooperative Group" with 1 trials as a collaborator, "LDR Médical" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "NSABP Foundation Inc" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Hôpital Henri Mondor" are "Hepatitis C, Chronic" (2 trials), "Lymphoma" (2 trials), "Non-Hodgkin's Lymphoma" (2 trials), "Acute Myocardial Infarction" (1 trials) and "Advanced Hepatocellular Carcinoma (HCC)" (1 trials). Many other conditions were trialed in "Hôpital Henri Mondor" in a lesser frequency.

Most popular intervention types in "Hôpital Henri Mondor" are "Drug" (18 trials), "Biological" (2 trials), "Device" (2 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Abemaciclib" (2 trials), "RBV" (2 trials), "SOF" (2 trials) and "5 FU bolus" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Henri Mondor" are 25 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hôpital Henri Mondor". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Hôpital Henri Mondor, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Henri Mondor, 4 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".